Digoxin attenuates acute cardiac allograft rejection by antagonizing RORγt activity Academic Article uri icon

Overview

MeSH Major

  • Digoxin
  • Graft Rejection
  • Heart Transplantation
  • Nuclear Receptor Subfamily 1, Group F, Member 3

abstract

  • RORγt may be a promising therapeutic target to attenuate acute cardiac allograft rejection. Digoxin therefore provides a molecular basis for the design of novel immunosuppressive agents.

publication date

  • February 15, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/TP.0b013e31827a48f5

PubMed ID

  • 23296151

Additional Document Info

start page

  • 434

end page

  • 41

volume

  • 95

number

  • 3